Background: Trichotillomania appears to be a fairly common disorder, with high rates of
Introduction
Trichotillomania is characterized by repetitive pulling out of one's hair, leading to significant functional impairment (APA, 2013) . With a lifetime prevalence estimated between 1% and 3% , trichotillomania is common and is frequently associated with significant psychosocial impairment (Woods et al., 2006) . Trichotillomania's functional impairment has often been attributed, in substantial part, to, associated anxiety, but the directional relationship of trichotillomania to anxiety is still unsettled (Neal-Barnett et al., 2011). In fact, one study of 894 individuals with trichotillomania found that 83% reported anxiety associated with pulling (Woods et al., 2006) . One explanation for its association with anxiety is that trichotillomania is simply a behavioral response to anxiety. Research suggests that trichotillomania generally begins at an earlier age than co-occurring anxiety disorders (Grant et al., 2015) , and that hair pulling in some individuals seems to regulate unpleasant or aversive feelings (Woods et al., 2006) . Adults with trichotillomania frequently report that their pulling worsens By examining anxiety disorders within a large sample of adults with trichotillomania who had been systematically evaluated, we hoped to finally determine whether anxiety disorders influence the clinical presentation of trichotillomania and are associated with a unique cognitive presentation.
Methods

Subjects
The study included 165 adults (152 [92.1%] females; mean age = 32.0 ± 10.9 years) with current trichotillomania. Subjects were recruited for treatment, neuroimaging, 
NIMH Trichotillomania Severity Scale (NIMH-TSS) (Swedo et al. 1989). The
NIMH scale is a five-item, clinician-administered scale that rates hair-pulling symptoms during the past week. The items assess pulling frequency (both on the previous day and during the past week), urge intensity, urge resistance, subjective distress, and interference with daily activities.
Psychosocial functioning and quality of life were assessed with the following:
Sheehan Disability Scale (Sheehan 1983 ). The Sheehan Disability Scale is a valid and reliable, 3-item, self-report scale that assesses psychosocial functioning in 3 areas of life:
work, social or leisure activities, and home/family life. Scores on the scale range from 0 to 30. (Frisch et al.1993 ). The Quality of Life Inventory is a valid and reliable 16-item, self-report positive psychology scale that assesses areas of life such as health, love, work, recreation, home, friendships, self-esteem, and standard of living.
Quality of Life Inventory
Cognitive functioning. Participants completed two neuropsychological tasks in a quiet testing room, using a touch-screen computer, measuring response inhibition and cognitive flexibility respectively. Our rationale for selecting these two tests was that they were used in earlier research to explore cognition in trichotillomania and how it compares to OCD (e.g. Chamberlain et al., 2006) .
Data Analysis
Participants with trichotillomania and a current anxiety disorder (generalized anxiety disorder, panic disorder, social phobia, anxiety disorder NOS) were compared to trichotillomania subjects without a current anxiety disorder, on measures of current symptoms, psychosocial functioning, and cognition. Between-group differences were tested using ANOVA, or equivalent non-parametric tests as explicitly indicated in the text. All tests of hypotheses were performed using a two-sided significance level of .05.
Results
Of all participants, 38 (23.0%) had at least one current co-occurring anxiety disorder. Those with anxiety disorders did not differ significantly from those without on demographic variables of interest (Table 1 ).
There were several significant clinical differences in people with trichotillomania based on anxiety disorders. Those with anxiety disorder had more severe trichotillomania symptoms based on both self-report (MGH-HPS) and clinician-administered instruments (NIMH-TSS) assessing past-week symptoms (Table 1) . Those with anxiety disorders also showed relative impairment in the ability to suppress pre-potent motor responses, as measured using the Stop-Signal Task.
Rates of current psychiatric comorbidity generally did not differ based on anxiety disorders although major depressive disorder was more common among those with an anxiety disorder ( Table 2 ). Further examination of participants without anxiety disorders who did and did not have current depression failed to show any clinical differences, and therefore these findings suggest that the anxiety disorder associations are not due to having comorbid depression. A family history of OCD was more common in those who had an anxiety disorder ( Table 2) .
Discussion
In this study, we determined clinical and cognitive associations with anxiety disorders in individuals with a primary diagnosis of trichotillomania. In this large study of adults with trichotillomania, 23% had a co-occurring anxiety disorder. This rate of comorbidity is consistent with rates of anxiety disorders found in many other studies of trichotillomania (Panza et al., 2013; Keuthen et al., 2014).
In terms of clinical variables, this study demonstrated that adults with anxiety disorders and trichotillomania reported more severe pulling behavior than trichotillomania participants without anxiety disorders. In the only other study examining the clinical associations of comorbidity, anxiety disorders were not associated with any specific clinical findings regarding hair pulling (Houghton et al., 2016) . Given that many people report pulling more when under stress, this finding is consistent with these anecdotal reports. Pulling may serve to reduce anxiety in some self-soothing fashion.
Alternatively, after severe pulling, many report that they are embarrassed by the alopecia and more anxious in social situations. Our study did not examine the cause or effect nature of this comorbidity.
The finding that anxiety disorders were positively associated with trichotillomania severity is clinically important, and clinicians treating adults with trichotillomania should screen for anxiety disorders and may consider offering therapy focusing on the comorbid condition. Treatment of either the trichotillomania or the anxiety disorder could be complicated or even compromised by the presence of the other untreated condition.
Treating one disorder alone may not be effective if a comorbid disorder is exerting a causal or maintaining influence on the treated condition. Psychological therapies should address anxiety while identifying reasons for pulling or for worsening of pulling.
Relaxation techniques and alternative ways to deal with anxiety (other than pulling) might be useful. Furthermore, adults with trichotillomania and co-occurring anxiety disorders may require more intensive treatment services. To our knowledge, no research has been conducted regarding the treatment of comorbid anxiety disorders in adults with trichotillomania or the treatment of trichotillomania in adults with anxiety disorders.
One important clinical difference between those with and without anxiety disorder was that depression was more common in those with anxiety disorders. Anxiety and depression are commonly associated and so this finding is in part expected. Depression by itself did not result in differences in trichotillomania symptomatology and so it seems that it is the anxiety that is the driving force behind when trichotillomania and anxiety disorders resulted in greater hair pulling severity. It is even possible that depression is a secondary phenomenon -that is, as anxiety drives the hair pulling and depression results from the alopecia. Thus one possible explanation for the current finding on the stop-signal task is that relative baseline stop-signal impairment in trichotillomania, irrespective of cause, then leads to more pronounced anxiety responses to stressful stimuli over time, which might then lead to a formal anxiety disorder.
This study has several limitations. First, because a clinical sample was used, it is unclear how generalizable our results are to individuals with trichotillomania in the community. Second, although subjects were asked extensively about family history, no interviews were conducted with family members and no non-trichotillomania control groups were used. Third, this research used a cross-sectional analysis and, therefore, causal relationships cannot be confirmed; however, the analysis provides reliable measures of association. Despite these limitations, the study sample was relatively large, the inclusion/exclusion were fairly broad (inclusion of those who did or did not meet criteria for treatment studies) and the study used both self-report and intervieweradministered measures with strong psychometric properties. Lastly, statistical power would have been limited to detect more subtle clinical differences, i.e. group differences with smaller effect sizes. Detection of more subtle group differences would require a larger sample size, and this should be addressed in larger follow-up studies.
In conclusion, these results suggest that adults with trichotillomania and cooccurring anxiety disorders exhibit unique clinical differences. These clinical differences that exist, however, have treatment implications. Large studies examining the neurobiological differences in those with anxiety disorders are needed to fully understand the role of comorbidity in this disorder. Future research should also be directed at potential factors that may contribute differently to the etiology and pathophysiology of trichotillomania when comorbidity exists. Also greatly needed are treatment studies to identify whether evidence-based interventions should be tailored differently for those with trichotillomania and co-occurring anxiety disorders, or worse cognitive dysfunction. 
